Search

Search Constraints

You searched for: Issue Volume 68:Issue 4(2018)

Search Results

62. Influence of Progenitor‐Derived Regeneration Markers on Hepatitis C Virus–Related Cirrhosis Outcome (ANRS CO12 CirVir Cohort). Issue 4 (5th October 2018)

63. Institutional decision to adopt Y90 as primary treatment for hepatocellular carcinoma informed by a 1, 000‐patient 15‐year experience. Issue 4 (29th January 2018)

64. Integrative Epigenetic Analysis Reveals Therapeutic Targets to the DNA Methyltransferase Inhibitor Guadecitabine (SGI‐110) in Hepatocellular Carcinoma. Issue 4 (5th October 2018)

65. Intestine farnesoid X receptor agonist and the gut microbiota activate G‐protein bile acid receptor‐1 signaling to improve metabolism. Issue 4 (21st May 2018)

69. Lipotoxicity induces hepatic protein inclusions through TANK binding kinase 1–mediated p62/sequestosome 1 phosphorylation. Issue 4 (21st May 2018)